Timeline

Camille Chauvin
Post-doc
03 Feb 2023
publication

Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.

Read more
09 Oct 2020
project

Study of immune crosstalk in COVID-19 COVIMUNE

Read more